SPDR® S&P Biotech ETF (XBI)

109.52
Delayed Data
As of 4:54pm ET
 -5.05 / -4.41%
Today’s Change
108.71
Today|||52-Week Range
174.79
-22.20%
Year-to-Date

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").

Performance

1 month-13.53% 3 years+11.25%
3 months-17.11% 5 years+13.03%
1 year-15.56% Since inception+13.19%
Data through 12/02/2021

Quote Details

Previous close$114.57
Open day’s range108.72 – 115.07
Net asset value (NAV)112.03 (12/01/2021)
Daily volume14,164,115
Average volume (3 months)5,451,360
Data as of 4:54pm ET, 12/03/2021

Peer Comparisonvs. Health ETFs

 XBICategory
Performance 5-yr return+13.03%+13.75%
Expense Gross exp ratio0.35%1.00%
Risk 5 year sharpe ratio0.690.91
Net assets$7.1B$2.4B
Average market cap$2.8B$37.7B
Average P/E--25.0
Dividend / Share--0.29%

Competitors

RYH Invesco S&P 500® Equal Weight Health Ca...
VHT Vanguard Health Care Index Fund ETF Shar...
FHLC Fidelity MSCI Health Care Index ETF

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
CCXI ChemoCentryx Inc1.96%
DRNA Dicerna Pharmaceuticals Inc1.46%
MCRB Seres Therapeutics Inc1.43%
CYTK Cytokinetics Inc1.11%
APLS Apellis Pharmaceuticals Inc1.00%
ACAD ACADIA Pharmaceuticals Inc1.00%
LGND Ligand Pharmaceuticals Inc0.99%
RCUS Arcus Biosciences Inc0.97%
CDMO Avid Bioservices Inc0.95%
BMRN Biomarin Pharmaceutical Inc0.92%